ABOS
Price
$2.04
Change
-$0.03 (-1.45%)
Updated
Oct 2 closing price
Capitalization
166.33M
45 days until earnings call
Intraday BUY SELL Signals
CCXI
Price
$11.99
Change
+$0.37 (+3.18%)
Updated
Oct 2 closing price
Capitalization
671.19M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs CCXI

ABOS vs CCXI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABOS vs. CCXI commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and CCXI is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CCXI: Fundamental Ratings
CCXI
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSCCXI
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
70%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ABOS: $2.07 vs. CCXI: $11.62)
Brand notoriety: ABOS and CCXI are both not notable
ABOS represents the Biotechnology, while CCXI is part of the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: ABOS: 168% vs. CCXI: 69%
Market capitalization -- ABOS: $166.33M vs. CCXI: $671.19M
ABOS [@Biotechnology] is valued at $166.33M. CCXI’s [@Financial Conglomerates] market capitalization is $671.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $1.85 to $590.24B. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Financial Conglomerates] industry is $262.22M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green while CCXI’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CCXI’s FA Score: 1 green, 4 red.
According to our system of comparison, CCXI is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while CCXI’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • CCXI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than CCXI.

Price Growth

ABOS (@Biotechnology) experienced а -7.38% price change this week, while CCXI (@Financial Conglomerates) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.84%. For the same industry, the average monthly price growth was +0.54%, and the average quarterly price growth was +4.41%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Financial Conglomerates (+0.84% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
CCXI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPT10.380.61
+6.24%
Sprout Social
CHRW153.145.18
+3.50%
C.H. Robinson Worldwide
FG21.980.30
+1.38%
F&G Annuities & Life
BGLC1.21-0.01
-0.82%
Bionexus Gene Lab Corp
LUD3.49-0.46
-11.65%
Luda Technology Group Ltd

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-6.76%
CCXI - ABOS
48%
Loosely correlated
N/A
NKTX - ABOS
44%
Loosely correlated
-2.29%
RCKT - ABOS
44%
Loosely correlated
-1.52%
CRBU - ABOS
40%
Loosely correlated
-3.94%
EDIT - ABOS
39%
Loosely correlated
-1.95%
More

CCXI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCXI has been loosely correlated with SPRO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CCXI jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCXI
1D Price
Change %
CCXI100%
N/A
SPRO - CCXI
48%
Loosely correlated
+4.13%
ABOS - CCXI
48%
Loosely correlated
-6.76%
ANVS - CCXI
34%
Loosely correlated
-7.87%
IPHA - CCXI
34%
Loosely correlated
-2.45%
IDYA - CCXI
34%
Loosely correlated
-1.59%
More